Ligand Pharmaceuticals Inc Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 6.39M2.41M0.00M3.66M2.59M10.89M227.44M0.73M12.56M143.32M629.30M-9.58M-19.21M-28.14M-1.67M-4.03M
Depreciation and Depletion 2.10M0.50M0.30M0.30M0.30M0.20M0.20M0.40M0.90M1.50M1.50M2.40M3.80M2.90M2.30M
Share-based Compensation 3.37M2.33M3.35M4.07M5.67M11.27M12.46M18.89M24.91M20.85M24.52M30.73M38.78M60.28M25.74M41.09M
Deferred Taxes 13.40M1.20M-0.37M-0.41M192.13M-10.70M-44.52M-29.74M-74.83M19.05M8.62M-20.72M-11.70M15.80M
Cash from Discontinued Operations -3.16M0.24M-0.90M-0.64M
Gains from Investment Securities 10.10M9.04M-0.05M0.11M0.04M1.54M2.60M2.35M10.07M3.77M812.80M9.55M9.19M8.24M4.55M5.14M
Asset Writedowns and Impairment 0.50M5.30M-0.46M1.43M0.34M3.25M1.33M
Cash from Operations -33.80M-27.31M-1.17M1.06M21.33M20.57M41.73M60.73M88.57M194.06M-29.34M54.59M78.80M137.85M49.58M97.05M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.35M0.08M5.45M10.27M-1.48M-0.11M-0.02M1.32M1.33M
Amortization of Deferred Charges 21.85M1.70M1.70M3.69M10.27M10.93M11.62M43.95M29.99M23.08M16.69M0.73M0.24M0.49M
Depreciation & Amortization (CF) 4.63M2.21M2.79M2.73M2.66M2.66M2.63M11.29M10.96M12.78M18.36M25.69M51.07M51.53M36.52M35.24M
Change in Working Capital
Change in Receivables 0.62M0.38M3.92M-1.52M-2.37M10.41M-6.49M8.53M8.36M29.54M-25.46M26.06M28.62M-55.32M2.60M6.46M
Change in Inventory -1.11M-1.03M-0.65M-4.37M0.40M0.24M0.84M2.56M2.06M17.80M0.43M-12.06M10.87M-9.62M
Change in Accured Expenses -10.99M-13.45M-11.57M-4.80M-3.15M-3.12M-4.03M-2.37M-5.06M-4.53M-6.66M-1.25M2.81M-3.34M-4.70M13.90M
Change in Taxes 0.46M-0.32M11.22M-9.14M3.98M-1.58M1.78M-2.31M
Other Working Capital Changes -14.30M-5.94M-4.86M-1.85M-0.65M1.44M-2.23M-0.53M-0.87M2.93M-3.50M29.24M-17.87M-6.34M9.87M7.72M
Investing Activities
Capital Expenditures 0.52M0.07M0.08M0.59M0.38M0.01M0.09M1.85M2.16M0.89M2.55M4.46M8.76M17.92M3.52M1.82M
Sales of Property, Plant and Equipment 0.11M0.59M0.53M0.02M0.00M0.12M
Change in Intangibles 1.25M812.80M
Acquisitions 9.80M2.83M32.02M3.57M92.50M26.65M5.86M11.84M404.88M10.40M
Divestments 22.06M
Change in Acquisitions & Divestments 47.76M54.04M19.35M10.00M2.34M57.23M118.87M109.65M892.87M1494.85M644.15M154.23M209.56M148.76M229.37M
Cash from Investing Activities 24.77M14.54M-25.13M1.26M-4.97M-2.03M-112.86M-134.41M-79.18M-423.27M466.92M231.65M30.52M163.62M-11.68M-143.66M
Financing Activities
Other financing activities 8.34M5.71M16.90M0.95M0.43M
Cash from Financing Activities -3.69M-0.16M30.00M3.92M-16.46M130.03M8.36M-4.99M-7.52M328.58M-485.17M-310.55M-137.76M-275.99M-59.95M97.14M
Additional items
Exchange Rate Effect -0.21M0.08M-1.17M
Change in Cash -12.72M-12.69M3.69M5.34M-0.74M148.56M-62.77M-78.68M1.87M99.38M-47.59M-24.31M-28.44M25.48M-22.05M49.35M
Free Cash Flow -34.32M-27.38M-1.25M0.47M20.95M20.56M41.63M58.88M86.41M193.17M-31.89M50.13M70.04M119.93M46.06M95.23M
Net Cash Flow -12.72M-12.93M3.69M6.24M-0.10M148.56M-62.77M-78.68M1.87M99.38M-47.59M-24.31M-28.44M25.48M-22.05M50.52M